Marinus Pharmaceuticals Inc (MRNS) Insider Trading
- $8,519,952.00
- $19,499,721.73
- Aug. 5, 2024
- Vii Lp Canaan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 5, 2024 | CFO | 4,657 | $1.13 | Sell | $5,262.41 | |
| Aug. 5, 2024 | Insider | 3,820 | $1.14 | Sell | $4,354.80 | |
| Aug. 5, 2024 | SVP | 3,621 | $1.13 | Sell | $4,091.73 | |
| Aug. 5, 2024 | CEO | 12,145 | $1.13 | Sell | $13,723.85 | |
| Aug. 7, 2023 | CFO | 2,790 | $9.54 | Sell | $26,616.60 | |
| Aug. 7, 2023 | Insider | 2,385 | $9.52 | Sell | $22,705.20 | |
| Aug. 7, 2023 | SVP | 2,169 | $9.54 | Sell | $20,692.26 | |
| Aug. 7, 2023 | CEO | 6,413 | $9.55 | Sell | $61,244.15 | |
| Feb. 6, 2023 | Director | 1,018 | $6.54 | Sell | $6,657.72 | |
| Jan. 30, 2020 | CFO | 2,380 | $2.05 | Sell | $4,879.00 | |
| Dec. 13, 2019 | CEO | 100,000 | $1.62 | Buy | $162,000.00 | |
| May 16, 2019 | CFO | 24,211 | $5.03 | Sell | $121,781.33 | |
| Jan. 29, 2019 | CFO | 2,492 | $3.06 | Sell | $7,625.52 | |
| Jan. 28, 2019 | CEO | 8,142 | $3.13 | Sell | $25,484.46 | |
| Jan. 29, 2018 | CFO | 3,000 | $7.91 | Sell | $23,730.00 | |
| Jan. 18, 2018 | CEO | 9,566 | $6.28 | Sell | $60,074.48 | |
| Dec. 19, 2017 | Major Shareholder | 1,272,547 | $7.88 | Sell | $10,027,670.36 | |
| Dec. 15, 2017 | Major Shareholder | 822,547 | $8.10 | Sell | $6,662,630.70 | |
| Oct. 20, 2016 | Major Shareholder | 750,683 | $1.39 | Sell | $1,043,449.37 | |
| Aug. 8, 2016 | Major Shareholder | 149,154 | $1.50 | Sell | $223,731.00 | |
| Aug. 4, 2016 | Major Shareholder | 145,583 | $1.50 | Sell | $218,374.50 | |
| July 29, 2016 | Major Shareholder | 24,540 | $1.71 | Sell | $41,963.40 | |
| July 27, 2016 | Major Shareholder | 20,589 | $1.81 | Sell | $37,266.09 | |
| July 26, 2016 | Major Shareholder | 20,380 | $1.81 | Sell | $36,887.80 | |
| July 25, 2016 | Major Shareholder | 270,750 | $1.90 | Sell | $514,425.00 | |
| April 21, 2015 | Insider | 30,000 | $9.48 | Sell | $284,400.00 | |
| Aug. 5, 2014 | Major Shareholder | 419,744 | $8.00 | Buy | $3,357,952.00 | |
| Aug. 5, 2014 | Director | 625,000 | $8.00 | Buy | $5,000,000.00 |
Insiders are both buying and selling Marinus Pharmaceuticals Inc stock.
The insider traders at Marinus Pharmaceuticals Inc are: Vii Lp Canaan, Edward F Smith, Scott Braunstein, Steven Pfanstiel, Bain Capital Life Sciences Inv, Christopher Michael Cashman, Christina Shafer, Martha E Manning, Gail M Farfel, Domain Partners Vi, L.P., Anand Mehra, Seth H Z Fischer, and Stephen M Bloch
The most active insider trader at Marinus Pharmaceuticals Inc is Vii Lp Canaan with 6 trades.
Bain Capital Life Sciences Inv has sold the most Marinus Pharmaceuticals Inc stock with a total value of $26,717,971.42.
Stephen M Bloch has bought the most Marinus Pharmaceuticals Inc stock with a total value of $10,000,000.00.
The most recent insider trade for Marinus Pharmaceuticals Inc was on Aug. 5, 2024.
The single biggest insider buy for Marinus Pharmaceuticals Inc was from Stephen M Bloch with a total value of $5,000,000.00 on Aug. 5, 2014.
The single biggest insider sell for Marinus Pharmaceuticals Inc was from Bain Capital Life Sciences Inv with a total value of $10,027,670.36 on Dec. 19, 2017.